Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

0.04 

0.00 1.5%

as of Aug 22 '19

52 Week Range:

0.04 0.05


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, engages in the research, development, manufacture, commercialization, marketing, and sale of health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, vitamins, nutritional supplements, and cosmetics; licensing registration activities and the importation of finished agricultural goods; holding land and building; financing and trustee activities; investment in financial instruments, as well as vineyards and wineries; trading of biotechnology products and nutritional supplements; and the manufacturing, wholesale, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides services in the research and development of bio-technology and life sciences technology products. Further, it engages in the discovery, development, manufacture, and commercialization of drug products to treat pain and melanoma; and supply of raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments. Additionally, the company offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. is headquartered in Tai Po, Hong Kong.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 0.05
0.04
0.05
0.06
0.05
0.05
0.06
0.05
0.05
0.05
0.05
growth rate -20.0% 25.0% 20.0% -16.7% 0.0% 20.0% -16.7% 0.0% 0.0% 0.0%
Earnings BIT 320.98
310.43
278.68
317.04
182.61
383.14
growth rate -3.3% -10.2% 13.8% -42.4% 109.8%
Avg.PE 20.00
25.00
19.33
15.33
growth rate 25.0% -22.7% -20.7%
ROA -5.35
2.86
2.92
1.55
1.95
2.35
2.57
2.86
2.63
2.57
2.50
growth rate 100.0% 2.1% -46.9% 25.8% 20.5% 9.4% 11.3% -8.0% -2.3% -2.7%
ROE -7.47
4.08
4.00
2.31
3.26
4.39
5.47
6.45
5.94
5.79
5.92
growth rate 100.0% -2.0% -42.3% 41.1% 34.7% 24.6% 17.9% -7.9% -2.5% 2.3%
ROIC -5.10
3.26
3.55
2.67
2.92
3.61
3.94
4.19
3.82
3.79
3.80
growth rate 100.0% 8.9% -24.8% 9.4% 23.6% 9.1% 6.4% -8.8% -0.8% 0.3%
Cur. Ratio 2.30
2.93
1.28
2.37
2.06
1.30
2.63
1.19
0.70
1.53
1.67
growth rate 27.4% -56.3% 85.2% -13.1% -36.9% 102.3% -54.8% -41.2% 118.6% 9.2%
Quick Ratio 1.61
2.31
0.95
1.56
1.38
0.83
1.77
0.81
0.47
1.03
1.04
growth rate 43.5% -58.9% 64.2% -11.5% -39.9% 113.3% -54.2% -42.0% 119.2% 1.0%
Leverage 1.45
1.41
1.34
1.64
1.70
2.05
2.21
2.30
2.21
2.29
2.45
growth rate -2.8% -5.0% 22.4% 3.7% 20.6% 7.8% 4.1% -3.9% 3.6% 7.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 989.00
1,052.69
990.15
1,126.01
1,064.46
1,330.90
1,244.99
growth rate 6.4% -5.9% 13.7% -5.5% 25.0% -6.5%
Acct.Payable 292.00
392.56
341.55
305.90
336.57
407.20
358.83
growth rate 34.4% -13.0% -10.4% 10.0% 21.0% -11.9%
Cur.Assets 2,430.00
2,886.78
3,000.24
2,918.52
2,880.95
3,451.96
3,257.13
growth rate 18.8% 3.9% -2.7% -1.3% 19.8% -5.6%
Total Assets 9,300.00
10,219.78
10,297.35
9,512.81
9,486.37
10,583.66
10,438.45
growth rate 9.9% 0.8% -7.6% -0.3% 11.6% -1.4%
Cash 572.00
767.66
979.20
840.75
859.43
1,037.77
773.37
growth rate 34.2% 27.6% -14.1% 2.2% 20.8% -25.5%
Inventory 796.00
952.91
971.15
923.38
937.50
1,066.93
1,227.18
growth rate 19.7% 1.9% -4.9% 1.5% 13.8% 15.0%
Cur.Liabilities 1,178.00
2,215.74
1,142.48
2,444.57
4,097.01
2,261.93
1,948.09
growth rate 88.1% -48.4% 114.0% 67.6% -44.8% -13.9%
Liabilities 3,576.00
5,019.48
5,422.38
5,253.55
5,083.33
5,826.96
6,018.61
growth rate 40.4% 8.0% -3.1% -3.2% 14.6% 3.3%
LT Debt 2,356.00
2,760.93
4,227.86
2,759.00
924.00
3,402.07
3,892.25
growth rate 17.2% 53.1% -34.7% -66.5% 268.2% 14.4%
Equity 4,976.94
4,662.65
4,115.08
4,261.25
4,617.04
4,263.91
growth rate -6.3% -11.7% 3.6% 8.4% -7.7%
Common Shares 9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
9,611.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 111.00
187.45
279.19
212.26
171.39
92.03
194.05
growth rate 68.9% 48.9% -24.0% -19.3% -46.3% 110.9%
Cash Dividends 57.67
67.28
76.89
86.50
96.11
96.11
growth rate 16.7% 14.3% 12.5% 11.1% 0.0%
Cash From OA 435.00
267.06
324.52
303.71
438.91
134.57
230.69
growth rate -38.6% 21.5% -6.4% 44.5% -69.3% 71.4%
FCF -98.00
58.00
37.00
-18.00
346.00
96.00
178.00
61.00
229.00
40.00
-57.00
growth rate 100.0% -36.2% -100.0% 100.0% -72.3% 85.4% -65.7% 275.4% -82.5% -100.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 4,545.00
4,970.93
4,954.04
4,919.31
4,868.54
4,693.13
5,232.99
growth rate 9.4% -0.3% -0.7% -1.0% -3.6% 11.5%
Op.Income 198.00
320.98
310.43
278.68
317.04
182.61
383.14
growth rate 62.1% -3.3% -10.2% 13.8% -42.4% 109.8%
IBT 303.73
321.13
249.58
362.16
329.99
421.23
growth rate 5.7% -22.3% 45.1% -8.9% 27.7%
Net Income 198.00
229.01
263.56
218.86
252.96
258.40
263.00
growth rate 15.7% 15.1% -17.0% 15.6% 2.2% 1.8%
EPS -0.04
0.02
0.02
0.01
0.02
0.02
0.03
0.02
0.03
0.03
0.03
growth rate 100.0% 0.0% -50.0% 100.0% 0.0% 50.0% -33.3% 50.0% 0.0% 0.0%
Gross Profit 1,553.00
1,741.81
1,740.32
1,741.85
1,662.50
1,543.81
1,734.36
growth rate 12.2% -0.1% 0.1% -4.6% -7.1% 12.3%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 127.28
64.29
64.29
134.86
134.86
growth rate -49.5% 0.0% 109.8% 0.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 1,278.58
1,244.99
1,244.99
1,176.97
1,176.97
growth rate -2.6% 0.0% -5.5% 0.0%
Acct.Payable 432.45
358.83
358.83
301.85
301.85
growth rate -17.0% 0.0% -15.9% 0.0%
Cur.Assets 3,555.08
3,257.13
3,257.13
3,092.61
3,092.61
growth rate -8.4% 0.0% -5.1% 0.0%
Total Assets 10,585.47
10,438.45
10,438.45
10,444.94
10,444.94
growth rate -1.4% 0.0% 0.1% 0.0%
Cash 1,052.65
773.37
773.37
677.75
677.75
growth rate -26.5% 0.0% -12.4% 0.0%
Inventory 1,211.00
1,227.18
1,227.18
1,227.00
1,227.00
growth rate 1.3% 0.0% 0.0% 0.0%
Cur.Liabilities 1,894.37
1,948.09
1,948.09
1,339.04
1,339.04
growth rate 2.8% 0.0% -31.3% 0.0%
Liabilities 5,982.35
6,018.61
6,018.61
6,122.11
6,122.11
growth rate 0.6% 0.0% 1.7% 0.0%
LT Debt 3,921.09
3,892.25
3,892.25
4,339.60
4,339.60
growth rate -0.7% 0.0% 11.5% 0.0%
Equity 4,460.76
4,263.91
4,263.91
4,175.32
4,175.32
growth rate -4.4% 0.0% -2.1% 0.0%
Common Shares 961.11
961.11
961.11
961.11
961.11
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 97.03
97.03
97.03
growth rate 0.0% 0.0%
Cash Dividends 48.06
48.06
48.06
48.06
48.06
growth rate 0.0% 0.0% 0.0% 0.0%
Cash From OA 52.82
62.53
62.53
85.02
85.02
growth rate 18.4% 0.0% 36.0% 0.0%
FCF -44.21
-34.50
-34.50
growth rate 0.0% 0.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 1,270.61
1,345.89
1,345.89
1,298.26
1,298.26
growth rate 5.9% 0.0% -3.5% 0.0%
Op.Income 127.28
64.29
64.29
134.86
134.86
growth rate -49.5% 0.0% 109.8% 0.0%
IBT 107.49
103.12
103.12
103.65
103.65
growth rate -4.1% 0.0% 0.5% 0.0%
Net Income 85.47
46.03
46.03
85.63
85.63
growth rate -46.1% 0.0% 86.0% 0.0%
Gross Profit 425.59
441.59
441.59
431.44
431.44
growth rate 3.8% 0.0% -2.3% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (8.54)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 12.67 12.67
EPS / Growth 0.00

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 0.01 1.01 1.01
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-98.0%
0.00
-98.0%
MOS Price 0.00 0.00 0.00
IRT 12.46 12.46 12.46

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.